PMC:7784830 / 10321-10540 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"171","span":{"begin":108,"end":120},"obj":"Species"}],"attributes":[{"id":"A171","pred":"tao:has_database_id","subj":"171","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vir Biotechnology VIR-7831 and VIR-7832 are two monoclonal antibodies that target the spike protein of the corona virus and enter via ACE2 cell receptor. Vir has collaborations for development of these antibodies [60]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T90","span":{"begin":0,"end":154},"obj":"Sentence"},{"id":"T91","span":{"begin":155,"end":219},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vir Biotechnology VIR-7831 and VIR-7832 are two monoclonal antibodies that target the spike protein of the corona virus and enter via ACE2 cell receptor. Vir has collaborations for development of these antibodies [60]"}